Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - AMS:CRBN - NL0010583399 - Common Stock

17.605 EUR
-0.04 (-0.25%)
Last: 11/6/2025, 5:29:58 PM
Fundamental Rating

5

Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 66 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN is cheap, but on the other hand it scores bad on growth. These ratings could make CRBN a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRBN had positive earnings in the past year.
In the past year CRBN had a positive cash flow from operations.
In the past 5 years CRBN has always been profitable.
CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

CRBN has a better Return On Assets (4.55%) than 71.21% of its industry peers.
With a decent Return On Equity value of 9.12%, CRBN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
CRBN has a Return On Invested Capital of 9.19%. This is in the better half of the industry: CRBN outperforms 78.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.12%.
The last Return On Invested Capital (9.19%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROIC 9.19%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CRBN (5.11%) is better than 63.64% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
CRBN has a Operating Margin of 8.68%. This is in the better half of the industry: CRBN outperforms 62.12% of its industry peers.
CRBN's Operating Margin has declined in the last couple of years.
CRBN's Gross Margin of 26.10% is on the low side compared to the rest of the industry. CRBN is outperformed by 60.61% of its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRBN has less shares outstanding than it did 1 year ago.
CRBN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CRBN has an Altman-Z score of 2.70. This is not the best score and indicates that CRBN is in the grey zone with still only limited risk for bankruptcy at the moment.
CRBN has a Altman-Z score of 2.70. This is in the better half of the industry: CRBN outperforms 63.64% of its industry peers.
CRBN has a debt to FCF ratio of 4.95. This is a neutral value as CRBN would need 4.95 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.95, CRBN is doing good in the industry, outperforming 75.76% of the companies in the same industry.
A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
CRBN has a Debt to Equity ratio (0.39) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Altman-Z 2.7
ROIC/WACC1.44
WACC6.38%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CRBN (1.21) is worse than 81.82% of its industry peers.
CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CRBN (0.60) is worse than 89.39% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for CRBN have decreased strongly by -68.99% in the last year.
Measured over the past years, CRBN shows a very strong growth in Earnings Per Share. The EPS has been growing by 49.47% on average per year.
CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
Measured over the past years, CRBN shows a small growth in Revenue. The Revenue has been growing by 5.70% on average per year.
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

Based on estimates for the next years, CRBN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.18% on average per year.
The Revenue is expected to decrease by -0.36% on average over the next years.
EPS Next Y38.56%
EPS Next 2Y23.47%
EPS Next 3Y18.97%
EPS Next 5Y13.18%
Revenue Next Year-0.98%
Revenue Next 2Y0.93%
Revenue Next 3Y1.99%
Revenue Next 5Y-0.36%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.72, the valuation of CRBN can be described as correct.
Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than 74.24% of the companies in the same industry.
CRBN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.13.
With a Price/Forward Earnings ratio of 11.47, the valuation of CRBN can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBN indicates a rather cheap valuation: CRBN is cheaper than 83.33% of the companies listed in the same industry.
CRBN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.72
Fwd PE 11.47
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than CRBN, based on the Enterprise Value to EBITDA ratio.
CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 92.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.28
EV/EBITDA 7.51
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRBN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 18.97% in the coming years.
PEG (NY)0.41
PEG (5Y)0.32
EPS Next 2Y23.47%
EPS Next 3Y18.97%

6

5. Dividend

5.1 Amount

CRBN has a Yearly Dividend Yield of 3.63%.
Compared to an average industry Dividend Yield of 3.21, CRBN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, CRBN pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

56.19% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.19%
EPS Next 2Y23.47%
EPS Next 3Y18.97%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (11/6/2025, 5:29:58 PM)

17.605

-0.04 (-0.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners91.06%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.03B
Revenue(TTM)1.30B
Net Income(TTM)66.20M
Analysts77.14
Price Target22.79 (29.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.19%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.54%
PT rev (3m)-10.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 15.72
Fwd PE 11.47
P/S 0.79
P/FCF 10.28
P/OCF 6.09
P/B 1.41
P/tB 1.62
EV/EBITDA 7.51
EPS(TTM)1.12
EY6.36%
EPS(NY)1.53
Fwd EY8.72%
FCF(TTM)1.71
FCFY9.73%
OCF(TTM)2.89
OCFY16.43%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.41
PEG (5Y)0.32
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 9.12%
ROCE 10.92%
ROIC 9.19%
ROICexc 9.57%
ROICexgc 10.55%
OM 8.68%
PM (TTM) 5.11%
GM 26.1%
FCFM 7.7%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.95
Debt/EBITDA 1.43
Cap/Depr 81.01%
Cap/Sales 5.3%
Interest Coverage 7.03
Cash Conversion 85.4%
Profit Quality 150.76%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.7
F-Score6
WACC6.38%
ROIC/WACC1.44
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.99%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y38.56%
EPS Next 2Y23.47%
EPS Next 3Y18.97%
EPS Next 5Y13.18%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-0.98%
Revenue Next 2Y0.93%
Revenue Next 3Y1.99%
Revenue Next 5Y-0.36%
EBIT growth 1Y54.53%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year132.41%
EBIT Next 3Y36.9%
EBIT Next 5Y20.56%
FCF growth 1Y171.85%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y118.83%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


Can you provide the valuation status for CORBION NV?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CRBN stock?

The Price/Earnings (PE) ratio for CORBION NV (CRBN.AS) is 15.72 and the Price/Book (PB) ratio is 1.41.


Can you provide the dividend sustainability for CRBN stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.19%.